UNSPSC 51285204: Trimethoprim hydrochloride

This classification denotes a dihydrofolate reductase inhibitor with the molecular formula C14H18N4O3.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9XE000OU9B. The term trimethoprim hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule trimethoprim hydrochloride under HS 29335995 and SITC 51576. SMILES: COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N.CL.

UNSPSC 51285204 Trimethoprim hydrochloride is a Commodity code that nominally covers a specific antibiotic pharmaceutical product, yet recent state and local solicitations tagged under this code reveal a substantial mismatch: the opportunities actually being posted involve broad medical and pharmaceutical procurement categories—naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products, direct-to-manufacturer prescription programs, and emergency medical supplies—rather than trimethoprim hydrochloride specifically. State and local issuing bodies posting under this code include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple states including Oregon). The actual work involves competitive bidding for pharmaceutical inventory, medical consumables, and emergency response supplies with quarterly or annual replenishment cycles, multi-year contract terms with renewal options, and compliance requirements including cGMP certification, FDA compliance, expiration-date management, and insurance coverage.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023); the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a March 13, 2026 deadline, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities, with proposals due March 26, 2026 and evaluation weighted 75 percent on price competitiveness; and the Texas Health and Human Services Commission RFI issued April 3, 2026 exploring vendor capabilities for direct-to-manufacturer prescription programs. The code's recent activity does not cleanly reflect its nominal scope, suggesting either broad tagging practices within procurement offices or a data-classification issue requiring clarification before pursuing opportunities under this specific code.